InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,099.96
(
1.02%
)
US TECH 100
17,244.80
(
1.57%
)
Dow Jones
38,239.66
(
0.40%
)
Brent Oil
88.17
(
0.00%
)
Bitcoin
63,618.55
(
0.33%
)
Post# of 4273
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

iwant2barafter

Send PM Follow Ignore
Followers 20
Posts 1137
Boards Moderated 0
Alias Born 10/31/2008

iwant2barafter

Re: None

Thursday, 01/25/2018 2:12:30 PM

Thursday, January 25, 2018 2:12:30 PM

Post# of 4273
This is going to $7-$10. Now 2 FDA approvals, new CEO, and potential for buyout or licensing overseas deals, it is worth the risk/reward at these levels for the big payoff.

When shorts have to cover it could possible make it run closer to $10.

4 our 5 analyst have this is a buy with average price target over $7.

BlackRock added a TON of new shares to their portfolio this month.

Someone knows something and just a matter of time.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up